Loading...
Loading...
India's dexamethasone imports from UNITED STATES total $886.1K across 297 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $209.3K in import value; the top 5 suppliers together control 60.9% of this origin. Leading Indian buyers include MICRO LABS LIMITED. This corridor reflects India's pharmaceutical import demand for dexamethasone — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Dexamethasone supplier from UNITED STATES to India, with import value of $209.3K across 8 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, PAR STERILE PRODUCTS, MS SUN PHARMACEUTICAL INDUSTRIES INC, AGRACE PHARMA., AMSTERDAM PHARMA(APTEKA RX INC.) — collectively account for 60.9% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $209.3K | 8 | 23.6% |
| 2 | PAR STERILE PRODUCTS | $116.8K | 2 | 13.2% |
| 3 | MS SUN PHARMACEUTICAL INDUSTRIES INC | $74.4K | 1 | 8.4% |
| 4 | AGRACE PHARMA. | $70.8K | 3 | 8.0% |
| 5 | AMSTERDAM PHARMA(APTEKA RX INC.) | $68.7K | 6 | 7.8% |
| 6 | RAFF & HALL PHARMACY | $40.9K | 7 | 4.6% |
| 7 | PHARMAQUELLE LLC | $37.3K | 5 | 4.2% |
| 8 | ESPEE BIOPHARMA FINECHEM LLC | $35.8K | 6 | 4.0% |
| 9 | BILCARE GCS INC. | $33.7K | 2 | 3.8% |
| 10 | AMSTERDAM PHARMA(APTEKA RX INC) | $23.2K | 2 | 2.6% |
| 11 | M/S. SUN PHARMACEUTICAL INDUSTRIES | $21.3K | 7 | 2.4% |
| 12 | SPRING BIO SOLUTION | $16.5K | 2 | 1.9% |
| 13 | AMSTERDAM PHARMA | $16.5K | 2 | 1.9% |
| 14 | RAFF HALL PHARMACY | $12.6K | 6 | 1.4% |
| 15 | REGIONAL PHARMACY | $12.5K | 7 | 1.4% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MICRO LABS LIMITED | $164.2K | 8 | 18.5% |
| 2 | INDOCO REMEDIES LIMITED | $144.6K | 22 | 16.3% |
| 3 | PAR FORMULATIONS PRIVATE LIMITED | $116.8K | 2 | 13.2% |
| 4 | AUROBINDO PHARMA LTD | $96.9K | 10 | 10.9% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $75.1K | 2 | 8.5% |
| 6 | DR.REDDY'S LABORATORIES LTD | $69.0K | 6 | 7.8% |
| 7 | MANKIND PHARMA LIMITED | $52.7K | 20 | 6.0% |
| 8 | FDC LIMITED | $28.7K | 8 | 3.2% |
| 9 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI | $24.1K | 4 | 2.7% |
| 10 | SUN PHARMACEUTICAL MEDICARE LIMITED | $20.6K | 6 | 2.3% |
| 11 | MICRO LABS LTD | $19.9K | 1 | 2.2% |
| 12 | MANKIND PHARMA LTD | $19.8K | 3 | 2.2% |
| 13 | HETERO LABS LIMITED | $8.7K | 8 | 1.0% |
| 14 | SOMERSET THERAPEUTICS LIMITED | $7.3K | 1 | 0.8% |
| 15 | HETERO LABS LIMITED | $6.8K | 11 | 0.8% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Dexamethasone suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, PAR STERILE PRODUCTS, MS SUN PHARMACEUTICAL INDUSTRIES INC. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $209.3K USD across 8 shipments. India imported Dexamethasone worth $886.1K USD from UNITED STATES in total across 297 shipments.
India imported Dexamethasone worth $886.1K USD from UNITED STATES across 297 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Dexamethasone sourced from UNITED STATES include MICRO LABS LIMITED, INDOCO REMEDIES LIMITED, PAR FORMULATIONS PRIVATE LIMITED. The largest buyer is MICRO LABS LIMITED with $164.2K in imports across 8 shipments.
The total value of Dexamethasone imports from UNITED STATES to India is $886.1K USD, across 297 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
297 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists